title: PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP.
abstract: Implant-associated infection is becoming more and more challenging to the healthcare industry worldwide due to increasing antibiotic resistance, transmission of antibiotic resistant bacteria between animals and humans, and the high cost of treating infections. In this study, we disclose a new strategy that may be effective in preventing implant-associated infection based on the potential antimicrobial properties of platelet-rich plasma (PRP). Due to its well-studied properties for promoting healing, PRP (a biological product) has been increasingly used for clinical applications including orthopaedic surgeries, periodontal and oral surgeries, maxillofacial surgeries, plastic surgeries, sports medicine, etc. PRP could be an advanced alternative to conventional antibiotic treatments in preventing implant-associated infections. The use of PRP may be advantageous compared to conventional antibiotic treatments since PRP is less likely to induce antibiotic resistance and PRP's antimicrobial and healing-promoting properties may have a synergistic effect on infection prevention. It is well known that pathogens and human cells are racing for implant surfaces, and PRP's properties of promoting healing could improve human cell attachment thereby reducing the odds for infection. In addition, PRP is inherently biocompatible, and safe and free from the risk of transmissible diseases. For our study, we have selected several clinical bacterial strains that are commonly found in orthopaedic infections and examined whether PRP has in vitro antimicrobial properties against these bacteria. We have prepared PRP using a twice centrifugation approach which allows the same platelet concentration to be obtained for all samples. We have achieved consistent antimicrobial findings and found that PRP has strong in vitro antimicrobial properties against bacteria like methicillin-sensitive and methicillin-resistant Staphylococcus aureus, Group A Streptococcus, and Neisseria gonorrhoeae. Therefore, the use of PRP may have the potential to prevent infection and to reduce the need for costly post-operative treatment of implant-associated infections.
authors.affiliation: Department of Orthopaedics, School of Medicine, West Virginia University, USA.
authors.forename: Hongshuai
authors.initials: H
authors.lastname: Li
authors.forename: Bingyun
authors.initials: B
authors.lastname: Li
mesh_terms: D000818:Animals; D001424:Bacterial Infections / Q000517:prevention & control*; D001672:Biocompatible Materials / Q000494:pharmacology; D001688:Biological Products / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D053657:Platelet-Rich Plasma; D016459:Prosthesis-Related Infections / Q000517:prevention & control*; D011817:Rabbits; D013211:Staphylococcus aureus / Q000187:drug effects
chemical_list: D001672:Biocompatible Materials; D001688:Biological Products